| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000023653 |
| Receipt No. | R000027188 |
| Scientific Title | Treatment and prognosis of heart valve registry |
| Date of disclosure of the study information | 2016/08/17 |
| Last modified on | 2020/08/20 (Ver. 15) |
| Basic information | ||
| Public title | Treatment and prognosis of heart valve registry | |
| Acronym | Heart valve registry | |
| Scientific Title | Treatment and prognosis of heart valve registry | |
| Scientific Title:Acronym | Heart valve registry | |
| Region |
|
|
| Condition | ||
| Condition | aortic stenosis/mitral regurgitation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | 1. We reveal the natural history about occurrence of cardiovascular events, the pace of the illness and that factor of the patients of aortic stenosis/mitral regurgitation. And we reveal the proper timing to offer invasive procedure.
2. We record detail of contents of procedure (surgical operation, Transcatheter Aortic Valve Implantation and Mitral Clip) and follow-up, we reveal the incidence of adverse events related to procedure or surgical result. In addition, we reveal factors affecting the incidence of adverse events and the prognosis after procedure. |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | During follow the natural history:
1. Mortality (all cause mortality, cardiovascular death, non-cardiovascular death) 2. Invasive procedure (surgical aortic valve replacement, mitral valve replacement, Transcatheter Aortic Valve Implantation, mitral valvuloplasty and Mitral Clip) 3. Admission of heart failure 4. Progression of heart valve by transthoracic echocardiography (increase of max velocity and pressure gradient, decrease of aortic valve area, and exacerbation of mitral regurgitation) After the invasive procedure: 1. Perioperative period: in-hospital death, complication (myocardial infarction, cardiac tamponade, vascular accident, auriculoventricular block for needing pacemaker, cerebral infarction, bleeding for needing blood transfusion) 2. Follow-up 1year, 2year, 3year, 4year, 5year after procedure: presence or absence of admission of heart failure, presence or absence of the death (cardiovascular death, non-cardiovascular death) |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients who undergo transthoracic echocardiography at Keio University hospital and satisfy the following any items.
A. A patient who has more than moderate aortic valvular stenosis B. A patient who has more than moderate mitral regurgitation |
|||
| Key exclusion criteria | The patients who are under the 20 years old or who are found unfit to be respondent to a survey by physician-in-charge | |||
| Target sample size | 5000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Keio University Hospital | ||||||
| Division name | Department of cardiology | ||||||
| Zip code | 160-8582 | ||||||
| Address | 35, Shinanomachi, Shinjyuku-ku, Tokyo | ||||||
| TEL | 03-3353-1211 | ||||||
| k-hayashida@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Keio University Hospital | ||||||
| Division name | Department of cardiology | ||||||
| Zip code | 160-8582 | ||||||
| Address | 35, Shinanomachi, Shinjyuku-ku, Tokyo | ||||||
| TEL | 03-3353-1211 | ||||||
| Homepage URL | |||||||
| nobuhiro_yossi@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | OCEAN-SHD organization |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Edwards Lifesciences, Medtronic, Boston Scientific, and Daiichi-Sankyo Company. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics Committee of Keio University School of Medicine |
| Address | Shinjyuku-ku Shinanomachi 35, Tokyo |
| Tel | 03-3353-1211 |
| med-rinri-jimu@adst.keio.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Study design: An observational study
Way for subscription: Explain the content of this research verbally using an explanatory document and obtain consent to participate in this research. We present a information of study implementation and Opt-out document about this clinical research to Keio University Hospital Website, Clinical Research Promotion Center Website and Cardiovascular Internal Medicine Website, and we release the content of this study implementation. We give an Opt-out document to such patients needs in any way. The cases of the patient who refuse registration, we indicate so on the clinical record and we don't collect information. Term of registration: 5-years |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027188 |